img

Global Liposomal Irinotecan Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Liposomal Irinotecan Market Research Report 2024

Irinotecan, sold under the brand name Camptosar among others, is a medication used to treat colon cancer, and small cell lung cancer. 
According to Mr Accuracy reports new survey, global Liposomal Irinotecan market is projected to reach US$ 1148.2 million in 2029, increasing from US$ 741 million in 2022, with the CAGR of 6.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Liposomal Irinotecan market research.
The Liposomal Irinotecan market has been influenced by the need for more effective treatments for difficult-to-treat cancers, such as metastatic pancreatic cancer.
Clinical trials have been conducted to evaluate the safety and efficacy of Liposomal Irinotecan in various cancer settings. Clinical evidence supports its use in specific indications.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Liposomal Irinotecan market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Ipsen
Segment by Type
43mg
50mg

Segment by Application


Hospital
Drugs Store

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Liposomal Irinotecan report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Liposomal Irinotecan Market Overview
1.1 Product Overview and Scope of Liposomal Irinotecan
1.2 Liposomal Irinotecan Segment by Type
1.2.1 Global Liposomal Irinotecan Market Value Comparison by Type (2024-2034)
1.2.2 43mg
1.2.3 50mg
1.3 Liposomal Irinotecan Segment by Application
1.3.1 Global Liposomal Irinotecan Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Global Liposomal Irinotecan Market Size Estimates and Forecasts
1.4.1 Global Liposomal Irinotecan Revenue 2018-2029
1.4.2 Global Liposomal Irinotecan Sales 2018-2029
1.4.3 Global Liposomal Irinotecan Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Liposomal Irinotecan Market Competition by Manufacturers
2.1 Global Liposomal Irinotecan Sales Market Share by Manufacturers (2018-2024)
2.2 Global Liposomal Irinotecan Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Liposomal Irinotecan Average Price by Manufacturers (2018-2024)
2.4 Global Liposomal Irinotecan Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Liposomal Irinotecan, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Liposomal Irinotecan, Product Type & Application
2.7 Liposomal Irinotecan Market Competitive Situation and Trends
2.7.1 Liposomal Irinotecan Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Liposomal Irinotecan Players Market Share by Revenue
2.7.3 Global Liposomal Irinotecan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Liposomal Irinotecan Retrospective Market Scenario by Region
3.1 Global Liposomal Irinotecan Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Liposomal Irinotecan Global Liposomal Irinotecan Sales by Region: 2018-2029
3.2.1 Global Liposomal Irinotecan Sales by Region: 2018-2024
3.2.2 Global Liposomal Irinotecan Sales by Region: 2024-2029
3.3 Global Liposomal Irinotecan Global Liposomal Irinotecan Revenue by Region: 2018-2029
3.3.1 Global Liposomal Irinotecan Revenue by Region: 2018-2024
3.3.2 Global Liposomal Irinotecan Revenue by Region: 2024-2029
3.4 North America Liposomal Irinotecan Market Facts & Figures by Country
3.4.1 North America Liposomal Irinotecan Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Liposomal Irinotecan Sales by Country (2018-2029)
3.4.3 North America Liposomal Irinotecan Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Liposomal Irinotecan Market Facts & Figures by Country
3.5.1 Europe Liposomal Irinotecan Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Liposomal Irinotecan Sales by Country (2018-2029)
3.5.3 Europe Liposomal Irinotecan Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Liposomal Irinotecan Market Facts & Figures by Country
3.6.1 Asia Pacific Liposomal Irinotecan Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Liposomal Irinotecan Sales by Country (2018-2029)
3.6.3 Asia Pacific Liposomal Irinotecan Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Liposomal Irinotecan Market Facts & Figures by Country
3.7.1 Latin America Liposomal Irinotecan Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Liposomal Irinotecan Sales by Country (2018-2029)
3.7.3 Latin America Liposomal Irinotecan Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Liposomal Irinotecan Market Facts & Figures by Country
3.8.1 Middle East and Africa Liposomal Irinotecan Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Liposomal Irinotecan Sales by Country (2018-2029)
3.8.3 Middle East and Africa Liposomal Irinotecan Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Liposomal Irinotecan Sales by Type (2018-2029)
4.1.1 Global Liposomal Irinotecan Sales by Type (2018-2024)
4.1.2 Global Liposomal Irinotecan Sales by Type (2024-2029)
4.1.3 Global Liposomal Irinotecan Sales Market Share by Type (2018-2029)
4.2 Global Liposomal Irinotecan Revenue by Type (2018-2029)
4.2.1 Global Liposomal Irinotecan Revenue by Type (2018-2024)
4.2.2 Global Liposomal Irinotecan Revenue by Type (2024-2029)
4.2.3 Global Liposomal Irinotecan Revenue Market Share by Type (2018-2029)
4.3 Global Liposomal Irinotecan Price by Type (2018-2029)
5 Segment by Application
5.1 Global Liposomal Irinotecan Sales by Application (2018-2029)
5.1.1 Global Liposomal Irinotecan Sales by Application (2018-2024)
5.1.2 Global Liposomal Irinotecan Sales by Application (2024-2029)
5.1.3 Global Liposomal Irinotecan Sales Market Share by Application (2018-2029)
5.2 Global Liposomal Irinotecan Revenue by Application (2018-2029)
5.2.1 Global Liposomal Irinotecan Revenue by Application (2018-2024)
5.2.2 Global Liposomal Irinotecan Revenue by Application (2024-2029)
5.2.3 Global Liposomal Irinotecan Revenue Market Share by Application (2018-2029)
5.3 Global Liposomal Irinotecan Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Ipsen
6.1.1 Ipsen Corporation Information
6.1.2 Ipsen Description and Business Overview
6.1.3 Ipsen Liposomal Irinotecan Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Ipsen Liposomal Irinotecan Product Portfolio
6.1.5 Ipsen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Liposomal Irinotecan Industry Chain Analysis
7.2 Liposomal Irinotecan Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Liposomal Irinotecan Production Mode & Process
7.4 Liposomal Irinotecan Sales and Marketing
7.4.1 Liposomal Irinotecan Sales Channels
7.4.2 Liposomal Irinotecan Distributors
7.5 Liposomal Irinotecan Customers
8 Liposomal Irinotecan Market Dynamics
8.1 Liposomal Irinotecan Industry Trends
8.2 Liposomal Irinotecan Market Drivers
8.3 Liposomal Irinotecan Market Challenges
8.4 Liposomal Irinotecan Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Liposomal Irinotecan Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Liposomal Irinotecan Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Liposomal Irinotecan Market Competitive Situation by Manufacturers in 2022
Table 4. Global Liposomal Irinotecan Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Liposomal Irinotecan Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Liposomal Irinotecan Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Liposomal Irinotecan Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Liposomal Irinotecan Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Liposomal Irinotecan, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Liposomal Irinotecan, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Liposomal Irinotecan, Product Type & Application
Table 12. Global Key Manufacturers of Liposomal Irinotecan, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Liposomal Irinotecan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Irinotecan as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Liposomal Irinotecan Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Liposomal Irinotecan Sales by Region (2018-2024) & (K Units)
Table 18. Global Liposomal Irinotecan Sales Market Share by Region (2018-2024)
Table 19. Global Liposomal Irinotecan Sales by Region (2024-2029) & (K Units)
Table 20. Global Liposomal Irinotecan Sales Market Share by Region (2024-2029)
Table 21. Global Liposomal Irinotecan Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Liposomal Irinotecan Revenue Market Share by Region (2018-2024)
Table 23. Global Liposomal Irinotecan Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Liposomal Irinotecan Revenue Market Share by Region (2024-2029)
Table 25. North America Liposomal Irinotecan Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Liposomal Irinotecan Sales by Country (2018-2024) & (K Units)
Table 27. North America Liposomal Irinotecan Sales by Country (2024-2029) & (K Units)
Table 28. North America Liposomal Irinotecan Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Liposomal Irinotecan Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Liposomal Irinotecan Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Liposomal Irinotecan Sales by Country (2018-2024) & (K Units)
Table 32. Europe Liposomal Irinotecan Sales by Country (2024-2029) & (K Units)
Table 33. Europe Liposomal Irinotecan Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Liposomal Irinotecan Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Liposomal Irinotecan Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Liposomal Irinotecan Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Liposomal Irinotecan Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Liposomal Irinotecan Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Liposomal Irinotecan Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Liposomal Irinotecan Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Liposomal Irinotecan Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Liposomal Irinotecan Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Liposomal Irinotecan Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Liposomal Irinotecan Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Liposomal Irinotecan Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Liposomal Irinotecan Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Liposomal Irinotecan Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Liposomal Irinotecan Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Liposomal Irinotecan Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Liposomal Irinotecan Sales (K Units) by Type (2018-2024)
Table 51. Global Liposomal Irinotecan Sales (K Units) by Type (2024-2029)
Table 52. Global Liposomal Irinotecan Sales Market Share by Type (2018-2024)
Table 53. Global Liposomal Irinotecan Sales Market Share by Type (2024-2029)
Table 54. Global Liposomal Irinotecan Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Liposomal Irinotecan Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Liposomal Irinotecan Revenue Market Share by Type (2018-2024)
Table 57. Global Liposomal Irinotecan Revenue Market Share by Type (2024-2029)
Table 58. Global Liposomal Irinotecan Price (US$/Unit) by Type (2018-2024)
Table 59. Global Liposomal Irinotecan Price (US$/Unit) by Type (2024-2029)
Table 60. Global Liposomal Irinotecan Sales (K Units) by Application (2018-2024)
Table 61. Global Liposomal Irinotecan Sales (K Units) by Application (2024-2029)
Table 62. Global Liposomal Irinotecan Sales Market Share by Application (2018-2024)
Table 63. Global Liposomal Irinotecan Sales Market Share by Application (2024-2029)
Table 64. Global Liposomal Irinotecan Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Liposomal Irinotecan Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Liposomal Irinotecan Revenue Market Share by Application (2018-2024)
Table 67. Global Liposomal Irinotecan Revenue Market Share by Application (2024-2029)
Table 68. Global Liposomal Irinotecan Price (US$/Unit) by Application (2018-2024)
Table 69. Global Liposomal Irinotecan Price (US$/Unit) by Application (2024-2029)
Table 70. Ipsen Corporation Information
Table 71. Ipsen Description and Business Overview
Table 72. Ipsen Liposomal Irinotecan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Ipsen Liposomal Irinotecan Product
Table 74. Ipsen Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Liposomal Irinotecan Distributors List
Table 78. Liposomal Irinotecan Customers List
Table 79. Liposomal Irinotecan Market Trends
Table 80. Liposomal Irinotecan Market Drivers
Table 81. Liposomal Irinotecan Market Challenges
Table 82. Liposomal Irinotecan Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Liposomal Irinotecan
Figure 2. Global Liposomal Irinotecan Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Liposomal Irinotecan Market Share by Type in 2022 & 2029
Figure 4. 43mg Product Picture
Figure 5. 50mg Product Picture
Figure 6. Global Liposomal Irinotecan Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Liposomal Irinotecan Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Drugs Store
Figure 10. Global Liposomal Irinotecan Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Liposomal Irinotecan Market Size (2018-2029) & (US$ Million)
Figure 12. Global Liposomal Irinotecan Sales (2018-2029) & (K Units)
Figure 13. Global Liposomal Irinotecan Average Price (US$/Unit) & (2018-2029)
Figure 14. Liposomal Irinotecan Report Years Considered
Figure 15. Liposomal Irinotecan Sales Share by Manufacturers in 2022
Figure 16. Global Liposomal Irinotecan Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Liposomal Irinotecan Players: Market Share by Revenue in 2022
Figure 18. Liposomal Irinotecan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Liposomal Irinotecan Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Liposomal Irinotecan Sales Market Share by Country (2018-2029)
Figure 21. North America Liposomal Irinotecan Revenue Market Share by Country (2018-2029)
Figure 22. United States Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Liposomal Irinotecan Sales Market Share by Country (2018-2029)
Figure 25. Europe Liposomal Irinotecan Revenue Market Share by Country (2018-2029)
Figure 26. Germany Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Liposomal Irinotecan Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Liposomal Irinotecan Revenue Market Share by Region (2018-2029)
Figure 33. China Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Liposomal Irinotecan Sales Market Share by Country (2018-2029)
Figure 43. Latin America Liposomal Irinotecan Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Liposomal Irinotecan Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Liposomal Irinotecan Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Liposomal Irinotecan Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Liposomal Irinotecan by Type (2018-2029)
Figure 53. Global Revenue Market Share of Liposomal Irinotecan by Type (2018-2029)
Figure 54. Global Liposomal Irinotecan Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Liposomal Irinotecan by Application (2018-2029)
Figure 56. Global Revenue Market Share of Liposomal Irinotecan by Application (2018-2029)
Figure 57. Global Liposomal Irinotecan Price (US$/Unit) by Application (2018-2029)
Figure 58. Liposomal Irinotecan Value Chain
Figure 59. Liposomal Irinotecan Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed